An assessment by the statin muscle safety task force: 2014 update

232Citations
Citations of this article
185Readers
Mendeley users who have this article in their library.

Abstract

The National Lipid Association's Muscle Safety Expert Panel was charged with the duty of examining the definitions for statin-associated muscle adverse events, development of a clinical index to assess myalgia, and the use of diagnostic neuromuscular studies to investigate muscle adverse events. We provide guidance as to when a patient should be considered for referral to neuromuscular specialists and indications for the performance of a skeletal muscle biopsy. Based on this review of evidence, we developed an algorithm for the evaluation and treatment of patients who may be intolerant to statins as the result of adverse muscle events. The panel was composed of clinical cardiologists, clinical lipidologists, an exercise physiologist, and a neuromuscular specialist. © Published by Elsevier Inc. on behalf of National Lipid Association.

Cite

CITATION STYLE

APA

Rosenson, R. S., Baker, S. K., Jacobson, T. A., Kopecky, S. L., & Parker, B. A. (2014). An assessment by the statin muscle safety task force: 2014 update. Journal of Clinical Lipidology, 8(3 SUPPL). https://doi.org/10.1016/j.jacl.2014.03.004

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free